Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study

International Journal of Food Microbiology

Volumn 128, Issue 3, 2009, Pages 429-434

  Kawase, Manabu ^a   He, Fang ^a   Kubota, Akira ^a   Hiramatsu, Masaru ^a   Saito, Hiroshi ^b   Ishii, Toyota ^b   Yasueda, Hiroshi ^b   Akiyama, Kazuo ^b  

^a Yokohama Kanagawa   (Japan)

^b SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Allergic rhinitis; IL 5; Lactobacillus; Nasal blockage; Pollinosis

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 5; PLACEBO; PROBIOTIC AGENT; YOGHURT;

ADULT; ARTICLE; BACTERIAL STRAIN; BLOOD SAMPLING; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DOWN REGULATION; DRUG MECHANISM; FEMALE; FERMENTED PRODUCT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LACTIC ACID BACTERIUM; LACTOBACILLUS GASSERI; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLLEN ALLERGY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF CARE; SYMPTOM; TH2 CELL;

ADULT; CRYPTOMERIA; CULTURED MILK PRODUCTS; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-4; INTERLEUKIN-5; LACTOBACILLUS; LEUKOCYTES, MONONUCLEAR; MALE; POLLEN; PROBIOTICS; RHINITIS, ALLERGIC, SEASONAL; SPECIES SPECIFICITY; TREATMENT OUTCOME; YOGURT;

CRYPTOMERIA JAPONICA; LACTOBACILLUS; LACTOBACILLUS GASSERI; RHODOCOCCUS RHODOCHROUS;

EID: 57349170732     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2008.09.017     Document Type: Article

References (34)

1. Björkstén B. The intestinal microflora in allergic patients. Biosci. Microflora 20 (2002) 135-140
2. Björkstén B., Naaber P., Sepp E., and Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29 (1999) 342-346
3. Fujimura T., Futamura N., Midoro-Horiuti T., Togawa A., Goldblum R.M., Yasueda H., Saito A., Shinohara K., Masuda K., Kurata K., and Sakaguchi M. Isolation and characterization of native Cry j 3 from Japanese cedar (Cryptomeria japonica) pollen. Allergy 62 (2007) 547-553
4. Hashimoto M., Nigi H., Sakaguchi M., Inouye S., Imaoka K., Miyazawa H., Taniguchi Y., Kurimoto M., Yasueda H., and Ogawa T. Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis. Clin. Exp. Allergy 25 (1995) 848-852
5. He F., Ouwehand A.C., Isolauri E., Hashimoto H., Benno Y., and Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol. Med. Microbiol. 30 (2001) 43-47
6. Helin T., Haahtela S., and Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 57 (2002) 243-246
7. Ishida Y., Bandou I., Kanzato H., and Yamamoto N. Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria. Biosci. Biotechnol. Biochem. 67 (2003) 951-957
8. Ishida Y., Nakamura F., Kanzato H., Sawada D., Yamamoto N., Kagata H., Oh-Ida M., Takeuchi H., and Fujiwara S. Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci. Biotechnol. Biochem. 69 (2005) 1652-1660
9. Ishida Y., Nakamura F., Kanzato H., Sawada D., Hirata H., Nishimura A., Kajiamoto O., and Fujiwara S. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J. Dairy Sci. 88 (2005) 527-533
10. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., and Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001) 1076-1079
11. Kalliomäki M., Salminen S., Poussa T., Arvilommi H., and Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
12. Kalliomäki M., Salminen S., Poussa T., and Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 119 (2007) 1019-1021
13. Kawase M., He F., Kubota A., Hata J., Kobayakawa S., and Hiramatsu M. Inhibitory effect of Lactobacillus gasseri TMC0356 and Lactobacillus GG on enhanced vascular permeability of nasal mucosa in experimental allergic rhinitis of rats. Biosci. Biotechnol. Biochem. 70 (2006) 3025-3030
14. Kawase M., He F., Kubota A., Mizumachi K., and Hiramatsu M. Characterization of inhibitory effects of Lactobacilli against immunoglobulin E production in vitro and in vivo. Int. J. Probiotics and Prebiotics 2 (2007) 29-38
15. Kawase M., He F., Kubota A., Harata G., and Hiramatsu M. Orally administrated Lactobacillus gasseri TMC0356 and Lactobacillus GG alleviated nasal blockage of guinea pig with allergic rhinitis. Microbiol. Immunol. 51 (2007) 1109-1114
16. Laaksonen K., Waris M., Mäkelä M.J., Terho E.O., and Savolainen J. In vitro kinetics of allergen- and microbe-induced Il-4 and IFN-γ mRNA expression in PBMC of pollen-allergic patients. Allergy 58 (2003) 62-66
17. Majamaa H., and Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99 (1997) 179-185
18. Morita H., He F., Fuse T., Ouwehand A.C., Hashimoto H., Hosoda M., Mizumachi K., and Kurisaki J. Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci. Biotechnol. Biochem. 66 (2002) 1963-1966
19. Morita H., He F., Kawase M., Kubota A., Hiramatsu M., Kurisaki J., and Salminen S. Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMC0356. Microbiol. Immunol. 50 (2006) 701-706
20. Nabe T., Kubota K., Terada T., Takenaka H., and Kohno S. Effect of oral immunotherapy on nasal blockage in experimental allergic rhinitis. J. Pharm. Sci. 98 (2005) 380-387
21. Nakai Y., Ohashi Y., Kakinoki Y., Tanaka A., Washio Y., Nasako Y., Masamoto T., Sakamoto H., and Ohmoto Y. Allergen-induced mRNA expression of IL-5, but not of IL-4 and IFN-γ, in peripheral blood mononuclear cells is a key feature of clinical manifestation of seasonal allergic rhinitis. Arch. Otolaryngol. Head Neck Surg. 126 (2000) 992-996
22. Ohashi Y., Nakai Y., Tanaka A., Kakinoki Y., Masamoto T., Kato A., Washio Y., Yamada K., Hayashi M., and Ohmoto Y. Allergen-induced synthesis of interleukin-5, but not of IgE, is a key mechanism linked to symptomatic episodes of seasonal allergic rhinitis in sensitized individuals. Scand. J. Immunol. 47 (1998) 596-602
23. Okuda M., Baba K., Konno A., and Takenaka H. Practical guideline for the management of allergic rhinitis in Japan. Establishment Committee of the Clinical Guidelines for Allergic Rhinitis. 5th ed. (2005), Life Science, Tokyo 8-30 (in Japanese)
24. Pohjavuori E., Viljanen M., Korpela R., Kuitunen M., Tiittanen M., Vaarala O., and Savilahti E. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J. Allergy Clin. Immunol. 114 (2004) 131-136
25. Rautava S., Ruuskanen O., Salminen S., and Isolauri E. The hygiene hypothesis of atopic disease-an extanded version. J. Pediatr. Gastroenterol. Nutr. 38 (2004) 378-388
26. Sakaguchi M., Inouye S., Taniai M., Ando S., Usui M., and Matuhashi T. Identification of the second major allergen of Japanese cedar pollen. Allergy 45 (1990) 309-312
27. Sawada J., Morita H., Tanaka A., Salminen S., He F., and Matsuda H. Ingestion of heat-treated Lactobacillus GG prevents development of atopic dermatitis in NC/Nga Mice. Clin. Exp. Allergy 37 (2007) 296-303
28. Shida K., Makino K., Morishita A., Takamizawa K., Hachimura S., Ametani A., Sato T., Kumagai Y., Habu S., and Kaminogawa S. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int. Arch. Allergy Immunol. 115 (1998) 278-287
29. Strachan D.P. Hay fever, hygiene, and household size. Br. Med. J. 299 (1989) 1259-1260
30. Strachan D.P. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 55 Suppl 1 (2000) S2-S10
31. Tamura M., Shikina T., Morihana T., Hayama M., Kajimoto O., Sakamoto A., Kajimoto Y., Watanabe O., Nonaka C., Shida K., and Nanno M. Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial. Int. Arch. Allergy Immunol. 143 (2007) 75-82
32. Viljanen M., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., and Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60 (2005) 494-500
33. Xiao J.Z., Kondo S., Yanagisawa N., Takahashi N., Odamaki T., Iwabuchi N., Iwatsuki K., Kokubo S., Togashi H., Enomoto K., and Enomoto T. Effect of probiotic Bifidobacterium longum BB536 in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial. J. Investig. Allergol. Clin. Immunol. 16 (2006) 86-93
34. Yasueda H., Yui Y., Shimizu T., and Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria Japonica) pollen. J. Allergy Clin. Immunol. 71 (1983) 77-86